Search Medical Condition
Please enter condition
Please choose location
 

Tirgoviste, Romania Clinical Trials

A listing of Tirgoviste, Romania clinical trials actively recruiting patients volunteers.

RESULTS

Found (1) clinical trials

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes With a FRC Extension Period

The maximum duration for GLP1-RA patients will be approximately 29 weeks: an up to 2 week screening period, a 26 week treatment period (either randomized or uncontrolled), and a 3 or 9 day post-treatment safety followup period. Maximum duration for FRC patients will be approximately 55 weeks: an up to ...

Phase

0.0 miles

Learn More »